PRIMMO Study Protocol: A Phase II Study Combining PD-1 Blockade, Radiation and Immunomodulation to Tackle Cervical and Uterine Cancer

BMC Cancer - United Kingdom
doi 10.1186/s12885-019-5676-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

Breast Care
SurgeryOncology
2016English

A Phase II Multicenter Trial of Concurrent Chemoradiotherapy With Weekly Nedaplatin in Advanced Uterine Cervical Carcinoma: Tohoku Gynecologic Cancer Unit Study

Oncology Reports
MedicineCancer ResearchOncology
2008English

PD-1 Expression and Clinical PD-1 Blockade in B-Cell Lymphomas

Blood
BiochemistryImmunologyCell BiologyHematology
2018English

Oncolytic Virus and PD-1/PD-L1 Blockade Combination Therapy

Oncolytic Virotherapy
2018English

PD-1/PD-L1 Blockade: A New Promising Therapy for the Treatment of Pancreatic Cancer?

Pancreas - Open Journal
2018English

PD-1 Blockade in Renal Cell Carcinoma: To Equilibrium and Beyond

Cancer immunology research
Cancer ResearchImmunology
2014English

A Phase I Study of Concurrent Weekly Topotecan and Cisplatin Chemotherapy With Whole Pelvic Radiation Therapy in Locally Advanced Cervical Cancer: A Gynecologic Oncology Group Study

Gynecologic Oncology
GynecologyOncologyObstetrics
2012English

A Multicenter Phase II Study of S-1 for Gemcitabine-Refractory Biliary Tract Cancer

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2013English

Prospective Phase-Ii-Study Evaluating Postoperative Radiotherapy of Cervical and Endometrial Cancer Patients Using Protons – The APROVE-trial

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy